Old Web
English
Sign In
Acemap
>
Paper
>
Pelmeg®, a biosimilar pegfilgrastim developed in the context of evolving regulatory guidelines
Pelmeg®, a biosimilar pegfilgrastim developed in the context of evolving regulatory guidelines
2020
Karsten Roth
Hendrik Wessels
Josef Hoefler
Ulrike Scholz
Dirk Lehnick
Keywords:
Risk analysis (engineering)
Business
Biosimilar
Pegfilgrastim
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]